Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The BRIGHT Study (Device Name: HALO System)

NCT: NCT07745998 · NOT_YET_RECRUITING

NCT IDNCT07745998
StatusNOT_YET_RECRUITING
Start Date2026-12
Completion2027-06
SponsorIndigo Diabetes NV (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of the BRIGHT study is to evaluate safety and performance of the HALO SYSTEM in subjects with diabetes mellitus. The primary objectives of this clinical investigation are 1) the evaluation of sensor's performance by demonstrating sensor's accuracy and stability and 2) to confirm safe implantation of the Sensor and safety of the device during implantation.

Frequently Asked Questions

What is The BRIGHT Study (Device Name: HALO System)?

The BRIGHT Study (Device Name: HALO System) is a clinical trial registered under NCT07745998. Current status: NOT_YET_RECRUITING.

What is the status of NCT07745998?

The current status of NCT07745998 (The BRIGHT Study (Device Name: HALO System)) is: NOT_YET_RECRUITING.

When did The BRIGHT Study (Device Name: HALO System) start?

The BRIGHT Study (Device Name: HALO System) started on 2026-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.